Title Image

Noreen Schuck joins Dynamic42 as new lab assistant

Noreen Schuck joins Dynamic42 as new lab assistant

We are excited to announce that Noreen Schuck has joined us at the beginning of October to support our lab team.

With a growing demand for our organ-on-chip models as well, biochips Dynamic42 is eager to expand their lab team, therefore Noreen did join us at just the right time.

In 2017, Noreen completed her Bachelor at the University of Jena in biochemistry followed by a master’s in chemical biology which she completed in 2020. Initially, Noreen worked at Synlab as a lab assistant on Sars-CoV-2 virus diagnosis before she moved on to work at the Leibniz Institute for Natural Product Research and Infection Biology in Jena.

We are delighted that Noreen has now decided to join Dynamic42 to continue her work in organ chips which she already started during her master’s thesis at Prof. Lilienfeld-Toal research group at the University Hospital Jena.

Here is what she has to say:

I got to know the organ-on-chip model during my master thesis, and now I am excited I can join the team of Dynamic42 to keep working with the fascinating complex 3D cell culture models. Also, the ethical aspect to help reduce animal experiences is a great motivation to work with these.

You can connect with Noreen or learn more about our organ-on-a-chip platforms here.

Read more News:

cross section model biotech chip BC003

Press Release | Dynamic42 develops new generation of biotech chips for organ-on-chip technology

BC003: The special feature of the new chip is the spatial design with three culture chambers. This enables the cultivation of complex, three-dimensional tissue cultures.

Dr. Juliane Fischer joins Dynamic42 as Marketing Manager

We are delighted to announce that Dr. Juliane Fischer has joined our team and will from now on heading all Marketing efforts at Dynamic42.

Organ-on-Chip

Dynamic42 participates in EU project to develop innovative model systems for the evaluation of immunomodulatory therapeutics

We participate in the EU project to develop innovative model systems for the evaluation of immunomodulatory therapeutics.